Register Login

IONIS PHARMACEUTICALS INC (IONS)

Kordasiewicz Holly B. 🟡 adjusted position in 60.8K shares (4 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $74.05 ($11.0M) Transaction Date: Jun 12, 2026 | Filing ID: 000208

Full text
Register to leave comments
  • News bot June 16, 2026, 9:26 p.m.

    🔍 Kordasiewicz Holly B. (Executive)

    Company: IONIS PHARMACEUTICALS INC (IONS)

    Report Date: 2026-06-12

    Transaction Summary:

    • Total transactions: 10
    • Derivative instruments: 4
    • Holdings reported: 0
    • Total shares acquired: 60,846
    • Total shares sold: 121,692

    Detailed Transactions and Holdings:

    • Acquired 7,951 shares of Common Stock at $60.89 per share (Direct)
      Date: 2026-06-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 30,409.00 | transaction_form_type: 4
    • Acquired 21,000 shares of Common Stock at $60.89 per share (Direct)
      Date: 2026-06-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 51,409.00 | transaction_form_type: 4
    • Acquired 12,000 shares of Common Stock at $32.6 per share (Direct)
      Date: 2026-06-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 63,409.00 | transaction_form_type: 4
    • Acquired 19,895 shares of Common Stock at $56.78 per share (Direct)
      Date: 2026-06-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 83,304.00 | transaction_form_type: 4
    • Sold 41,004 shares of Common Stock at $73.0934 per share (Direct)
      Date: 2026-06-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 42,300.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 19,842 shares of Common Stock at $74.0503 per share (Direct)
      Date: 2026-06-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 22,458.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 12,000 shares of Non-Qualified Stock Option (right to buy) at $32.6 per share (Derivative)
      Date: 2026-06-12 | Code: M | Expires: 2032-01-02 | Exercise: 2023-01-03 | equity_swap_involved: 0 | transaction_form_type: 4
    • Sold 19,895 shares of Non-Qualified Stock Option (right to buy) at $56.78 per share (Derivative)
      Date: 2026-06-12 | Code: M | Expires: 2028-01-03 | Exercise: 2022-01-04 | equity_swap_involved: 0 | transaction_form_type: 4
    • Sold 7,951 shares of Non-Qualified Stock Option (right to buy) at $60.89 per share (Derivative)
      Date: 2026-06-12 | Code: M | Expires: 2027-01-01 | Exercise: 2021-01-02 | equity_swap_involved: 0 | shares_owned_after: 21,000.00 | transaction_form_type: 4
    • Sold 21,000 shares of Non-Qualified Stock Option (right to buy) at $60.89 per share (Derivative)
      Date: 2026-06-12 | Code: M | Expires: 2027-01-01 | Exercise: 2021-01-02 | equity_swap_involved: 0 | transaction_form_type: 4

    Footnotes:

    • F1: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 13, 2026
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.68 to $73.67 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.735 to $74.28 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.

Search

News categories